CVS Health is planning to split its massive business into two publicly traded companies, according to a report cited by Reuters, in a major restructuring that could change the U.S. pharmacy and healthcare industry.

The proposed separation would divide CVS's approximately 9,000 retail pharmacies from its pharmacy-benefit management business, Caremark, and health insurer Aetna.

One company would retain the insurance and pharmacy-benefit operations, alongside other healthcare services. The second, expected to operate as CVS Pharmacy, would include retail drugstores, mail-order pharmacy services and MinuteClinic locations.

The move would reverse CVS's long-standing strategy of combining pharmacy, insurance and prescription-benefit services under one corporate structure.

The restructuring comes amid growing regulatory scrutiny of pharmacy-benefit managers, which play a major role in prescription pricing and relationships between drug manufacturers, insurers and pharmacies.

Investors may view the separation as an opportunity to unlock value from the different businesses. However, the proposed breakup also raises questions about operational costs, commercial agreements and how the two companies would work together.